Today, SENTA (“Southern Ear, Nose, Throat and Allergy Physicians”), proudly announces that Allergy, Asthma & Immunology Associates of South Texas (“AllergySA”) is joining the physician led, patient focused alliance. With the addition of AllergySA, SENTA welcomes a key partner in Texas and expands its footprint into a new state and region. This partnership further solidifies SENTA’s substantial growth in early 2022.
AllergySA is a leading allergy practice in the San Antonio region with offices in three locations. For more than 30 years, their team of board-certified allergists and medical professionals have provided excellence in clinical care and innovative research for the treatment of allergic diseases, asthma, and immunologic disorders throughout South Texas.
“Our focus has always been to deliver outstanding care for our patients in South Texas. We are dedicated to improving the health and lives of our patients by providing comprehensive medical services in a timely and caring manner,” said Joseph Diaz, MD, Medical Director, AllergySA. “We look forward to continuing this mission with SENTA and the tremendous resources they provide.”
“We are thrilled to welcome Drs. Joseph Diaz and Lukena Karkhanis and their colleagues at AllergySA to the SENTA family,” said Adam Low, CEO, SENTA. “They have a long history of providing exceptional allergy and immunology care in their region, in addition to a strong dedication to research to advance our field. These attributes make them a welcome addition to our alliance and further expands on our key objective of providing the highest level of care to our patients across the South.”
If interested in learning more about a partnership with SENTA, contact the Chief Development Officer, Zack Usilton at [email protected].
About SENTA Partners
Southern Ear, Nose, Throat and Allergy Physicians (SENTA) is a leading community of the finest ENT and Allergy/Immunology specialists in the Southern region. SENTA is physician led and patient focused, providing the highest quality allergy, asthma, immunology, and otolaryngology care leading to better patient outcomes. Founded in 2019 with an investment from Shore Capital Partners, SENTA provides strategic, operational, and administrative support to our partner practices, empowering physicians to focus on their patients. For additional information on SENTA, please visit SENTAPARTNERS.com.
About Shore Capital Partners
Shore Capital, a Chicago-based private equity firm with offices in Nashville, is focused on microcap investments within the Healthcare, Food and Beverage, Business Services, and Real Estate industries. Shore supports management partners with capital, business development expertise, and industry knowledge to accelerate growth, fund acquisitions, and generate value for shareholders. Shore targets investments in proven, successful private companies with superior management teams, stable cash flow, and significant growth potential, including organic growth and growth through industry consolidation. Shore has approximately $3.0 billion of cumulative capital commitments through various investment vehicles. For more information, please visit shorecp.com.
Share this Article: